{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T02:24:30Z","timestamp":1648952670769},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2019,10,1]]},"DOI":"10.1001\/jamaoncol.2019.2304","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T15:31:46Z","timestamp":1567092706000},"page":"1497","source":"Crossref","is-referenced-by-count":3,"title":["Weakness and Myalgia in a Patient With Hepatocellular Carcinoma Undergoing Checkpoint Inhibitor Therapy"],"prefix":"10.1001","volume":"5","author":[{"given":"Pavan P.","family":"Shah","sequence":"first","affiliation":[{"name":"Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos G.","family":"Romo","sequence":"additional","affiliation":[{"name":"The Johns Hopkins Hospital, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Yarchoan","sequence":"additional","affiliation":[{"name":"Johns Hopkins University, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"3","key":"ccg190005r1","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1159\/000494078","article-title":"Lambert-Eaton myasthenic syndrome caused by nivolumab in a patient with squamous cell lung cancer.","volume":"10","author":"Nakatani","year":"2018","journal-title":"Case Rep Neurol"},{"issue":"4","key":"ccg190005r2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/1941874418778957","article-title":"Miller Fisher syndrome associated with immunotherapy for metastatic melanoma.","volume":"8","author":"Baird-Gunning","year":"2018","journal-title":"Neurohospitalist"},{"issue":"10","key":"ccg190005r3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11910-018-0878-7","article-title":"Neuromuscular complications of programmed cell death-1 (PD-1) inhibitors.","volume":"18","author":"Kao","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ccg190005r4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2016.12.001","article-title":"Neurological adverse events associated with immune checkpoint inhibitors: review of the literature.","volume":"73","author":"Cuzzubbo","year":"2017","journal-title":"Eur J Cancer"},{"key":"ccg190005r5","first-page":"1","article-title":"Neurological complications of immune checkpoint inhibitors: what happens when you \u2018take the brakes off\u2019 the immune system.","volume":"11","author":"Dalakas","year":"2018","journal-title":"Ther Adv Neurol Disorder"},{"issue":"2","key":"ccg190005r6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade.","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"ccg190005r7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1172\/JCI96798","article-title":"Early B cell changes predict autoimmunity following combination immune checkpoint blockade.","volume":"128","author":"Das","year":"2018","journal-title":"J Clin Invest"},{"key":"ccg190005r8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejca.2017.05.041","article-title":"Myasthenia gravis: an emerging toxicity of immune checkpoint inhibitors.","volume":"82","author":"Makarious","year":"2017","journal-title":"Eur J Cancer"},{"issue":"3","key":"ccg190005r9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"issue":"6","key":"ccg190005r10","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.clinph.2013.11.005","article-title":"Reliability of SFEMG in diagnosing myasthenia gravis: sensitivity and specificity calculated on 100 prospective cases.","volume":"125","author":"Padua","year":"2014","journal-title":"Clin Neurophysiol"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2749174\/jamaoncology_shah_2019_cg_190005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T22:37:12Z","timestamp":1570747032000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2749174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2019.2304","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,1]]}}}